DS-8201a 5.4 mg/kg Q3W + DS-8201a 6.4 mg/kg Q3W
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Advanced Colorectal Cancer
Conditions
Advanced Colorectal Cancer
Trial Timeline
Mar 5, 2021 → Dec 4, 2024
NCT ID
NCT04744831About DS-8201a 5.4 mg/kg Q3W + DS-8201a 6.4 mg/kg Q3W
DS-8201a 5.4 mg/kg Q3W + DS-8201a 6.4 mg/kg Q3W is a phase 2 stage product being developed by Daiichi Sankyo for Advanced Colorectal Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT04744831. Target conditions include Advanced Colorectal Cancer.
What happened to similar drugs?
16 of 20 similar drugs in Advanced Colorectal Cancer were approved
Approved (16) Terminated (1) Active (4)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04744831 | Phase 2 | Completed |
Competing Products
20 competing products in Advanced Colorectal Cancer